However, a relatively low VEGF‐D level does not rule out a diagnosis of LAM and, therefore, patients who do not show the most typical symptoms may still require a lung biopsy (Johnson et al, 2010; McCormack et al, 2016). This evidence concerns the gene VEGFD and lymphangioleiomyomatosis.